Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
Related Research units
Abstract
The clinical outcomes and safety of dalbavancin as primary and sequential treatment of gram-positive bacteremia with infective endocarditis were evaluated retrospectively. The clinical success rate was high (92.6%), but in 24 of 27 patients dalbavancin was used only after clearance of bacteria from the bloodstream.
Bibliographical data
Original language | English |
---|---|
ISSN | 1058-4838 |
DOIs | |
Publication status | Published - 16.08.2018 |
PubMed | 29659732 |
---|